Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2023-07-24 00:00:00 ET · period of report 2023-05-25 · accession 0001367644-23-000137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-07-24 | 2023-05-25+ | EBS | Zoon Kathryn C | Dir | S - Sale | $8.36 | -3,530 | 50.0K | -7% | -$29.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-25 | S | D | 1,700 | $8.38 | 51,801 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Zoon. |
| 2 | Common | Common Stock | 2023-06-02 | S | D | 1,830 | $8.35 | 49,971 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Zoon. |